NCT01276938

Exclusive Intraoperative Radiation Therapy for Breast Cancer

Tolerance Evaluation of Exclusive Intraoperative Radiation Therapy at Different Doses for Breast Cancer Conservative Treatment

• Status: Completed
• Phase: Phase 2 / Phase 3
• Study type: Interventional
• Enrollment: 40 (actual)
• Sponsor: IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy · Academic / Other
• Sex: Female
• Age: 45 Years – 85 Years
• Healthy volunteers: Not accepted

Summary

Aim of the study is to evaluate toxicity in breast cancer patients treated with two different doses of Intra Operative Radiotherapy

Conditions

• Breast Neoplasms
• Toxicity

Interventions

Type	Name	Description
RADIATION	21 Gy radiation	21 Gy radiation using electrons produced with mobile linear accelerator (energies ranging from 4 to 10 MeV)
RADIATION	18 Gy radiation	18 Gy radiation using electrons produced with mobile linear accelerator (energies ranging from 4 to 10 MeV)

Timeline

• Start date: 2009-04-01
• Primary completion: 2011-09-01
• Completion: 2011-09-01
• First posted: 2011-01-14
• Last updated: 2017-05-24

Locations

1 site across 1 country: Italy